ClinicalTrials.govpublic full text
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
spinal muscular atrophy, sma, spinal muscular atrophy type 2, spinal muscular atrophy type 3, neuromuscular manifestations, anti-myostatin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 880564
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.